Health and Healthcare

What Akcea Shareholders Get in the Ionis Buyout

xrrr / iStock

Akcea Therapeutics Inc. (NASDAQ: AKCA) stock jumped on Monday after it was announced that Ionis Pharmaceuticals Inc. (NASDAQ: IONS) would be acquiring all of its outstanding shares.

Under the terms of the deal, Ionis will acquire the shares for $18.15, which corresponds to a total transaction value of approximately $500 million on a fully diluted basis. The transaction is expected to be funded through existing cash resources.

Also, this transaction has been approved by both the Ionis and Akcea boards of directors and is expected to close in the fourth quarter of 2020.

Ultimately, the deal will help Ionis realize more financial upside from Akcea’s pipeline and commercial products. Accordingly, Ionis will gain full access to Akcea’s significant cash on hand of roughly $390 million and future cash flows to further invest in the company’s future and further support Ionis’ capital allocation strategy.

Akcea management noted that this transaction delivers immediate and certain value with a premium to Akcea shareholders. The close collaboration with Ionis has been key to enabling the launch of two commercial antisense medicines in just two years, as well as advancing a late-stage pipeline and securing important partnerships.

Accordingly, Akcea shareholders are getting a solid premium from this buyout. The 50-day and 200-day moving averages imply premiums of 44.3% and 16.5%, respectively.

Akcea stock traded up about 60% Monday morning, at $18.19 in a 52-week range of $8.00 to $22.79. The consensus price target is $27.00.

Ionis stock was up 2% to $53.92, in a 52-week range of $39.32 to $67.31. The consensus price target is $68.11.

Are You Still Paying With a Debit Card?

The average American spends $17,274 on debit cards a year, and it’s a HUGE mistake. First, debit cards don’t have the same fraud protections as credit cards. Once your money is gone, it’s gone. But more importantly you can actually get something back from this spending every time you swipe.

Issuers are handing out wild bonuses right now. With some you can earn up to 5% back on every purchase. That’s like getting a 5% discount on everything you buy!

Our top pick is kind of hard to imagine. Not only does it pay up to 5% back, it also includes a $200 cash back reward in the first six months, a 0% intro APR, and…. $0 annual fee. It’s quite literally free money for any one that uses a card regularly. Click here to learn more!

 

Flywheel Publishing has partnered with CardRatings to provide coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.